Insiders · Profile

Scott Randal W.

Director at BridgeBio Pharma. Filing since 17 Feb 2021. CIK 0001337801

Company
Date
Role
Action
Shares
Amount
Of holding
15 May 2026
Director
Sold on a plan
10,000
$671.46K
46.3%
17 Feb 2026
Director
Sold on a plan
10,000
$754.56K
46.3%
17 Nov 2025
Director
Sold on a plan
10,000
$666.47K
46.3%
4 Jun 2024
Director
Sold on a plan
1,500
$46.95K
27.3%
3 Jun 2024
Director
Sold on a plan
1,000
$28.84K
15.4%
1 Mar 2024
Director
Sold on a plan
2,500
$85.00K
27.8%
18 Dec 2023
Director
Sold on a plan
2,000
$80.00K
18.2%
1 Dec 2023
Director
Sold on a plan
2,500
$73.50K
18.5%
5 Sep 2023
Director
Sold on a plan
2,500
$75.00K
15.6%
17 Feb 2021
Director
Bought
16,000
$1.00M
320%
10 decisions on file.